Pseudotumor cerebri in acute promyelocytic leukemia patients on Intergroup Protocol 0129: clinical description and recommendations for new diagnostic criteria

BACKGROUND: Multiple randomized trials have demonstrated a benefit for all-trans retinoic acid (ATRA) in patients with acute promyelocytic leukemia (APL). Pseudotumor cerebri (PTC) is an infrequently reported adverse effect of ATRA. METHODS: We examined the incidence, clinical course, and outcomes o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Lymphoma Myeloma Leuk
Hlavní autoři: Coombs, Catherine C., DeAngelis, Lisa M., Feusner, James H., Rowe, Jacob M., Tallman, Martin S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028896/
https://ncbi.nlm.nih.gov/pubmed/26724834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2015.11.018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky